Good Growth Capital的动态

From targeted therapies to sustainable manufacturing, Catalent shares our perspective with The Medicine Maker on the future of the pharma and biopharma industries, highlighting key disruptors and potential improvements. "I am optimistic that the next decade will see real, transformative changes driving better outcomes for patients. Drug development and manufacturing can play a meaningful role, ultimately enhancing the overall well-being of individuals and communities worldwide." - David McErlane, Group President, Catalent Biologics Read the full article >> https://ow.ly/HXoF50TQZas #drugdevelopment #biologics

?? Dive into Knowledge with Our Latest Blog! ?? Discover in-depth information about the global drug discovery technologies industry, which is expected to expand at a 12.0% annual growth rate (CAGR) during the following five years, from $111.9 billion in 2024 to an astounding $197.0 billion by 2029! High-throughput screening, novel biologics, and AI-driven drug discovery are the main drivers of this boom, accelerating development timeframes and increasing efficiencies. ?? What is Drug Discovery Technology? It encompasses cutting-edge techniques used to identify new therapeutic candidates. These technologies streamline the complex drug development process by enabling faster and more accurate identification of promising compounds, transforming healthcare and patient outcomes globally. Discover the latest trends, growth drivers, and future opportunities shaping the next generation of pharmaceuticals. Join the movement toward innovative drug discovery technologies poised to redefine healthcare as we know it. https://bit.ly/4dqcFoy #DrugDiscovery #PharmaInnovation #HealthcareTech #Biotech #MarketForecast #Pharmaceuticals #Biologics #AIinHealthcare #GlobalMarkets #TechTrends #CAGR #HealthcareInnovation

Global Labeling & Regulatory Symposium Washington, DC | October 8-9 Kimpton Hotel Monaco Washington, DC, renowned for its leadership and innovation, is the perfect backdrop for this year’s Global Labeling & Regulatory Symposium. We’re excited to join industry leaders to discuss the future of healthcare and regulatory advancements. At Meitheal, we are focused on driving innovation in generics, expanding into biologics and biosimilars, and improving access to life-saving medicines. We look forward to connecting with you and sharing how our regulatory strategies are shaping a more sustainable future. Think sustainability, think Meitheal. #Generics #Biologics #Biosimilars

???????????????? ???????????????????????? ???? ?????????????? ???? ??????????????????! The current market conditions are looking promising. Transaction volumes in Biotech VC Financing have seen a slight increase compared to last year (H2), and even more encouragingly, the total amount raised has surged by 20%. ?? This positive trend indicates growing optimism and increased funding from biotech investors, especially when the technology and data is compelling. At Pharma Targeting, we specialize in helping pharmaceutical service and solution providers identify, qualify, and connect with these funded opportunities ahead of the market, including those in stealth mode. This proactive approach gives you a competitive edge! ???? With the end of year conferences also coming up and looking to capitalize on the upward trajectory, there hasn’t been a better time over the last 18+ months to get ahead. Reach out today to learn how Pharma Targeting's unique methodology can help you achieve your business development goals more efficiently! ? ?? #pharmaceutical #biologics #biotech #CDMO #CMO #CRO #drugdevelopment #drugmanufacturing #drugdelivery #preclinical #analyticaldevelopment #formulation #clinicaltrials #clinicaldevelopment #mAbs #smallmolecules #peptides #ATMP #VC

Meet our colleague Kristian Le Vay at #PEGSEurope in Barcelona, where he presented a poster on Drug Product Oriented mAb Developability Assessment. ??Take the opportunity to learn more about the #CoriolisEffect and how you can benefit from early developability assessment for your drug development: ??Get faster into the clinics ??Minimize risk ??Use advanced methods ??Benchmark against commercial antibodies ??Save your own resources and avoid costly late-stage failures ??https://lnkd.in/dJRDhKhT #CoriolisPharma #Pharmaceuticals #Biotech #drugdevelopment

We'd like to say a huge thank you to all of our presenters, facilitators and all of you who joined our Oligonucleotide Therapeutics Roundtable Xchange in?#SanDiego, February 28th. If you missed it, join us next time and take advantage of this unique highly interactive meeting format designed for maximum engagement and collaboration with your peers. For more information or to view full agendas of the upcoming roundtable meetings and secure your spot, please visit?https://lnkd.in/djSEqbRU Please note: Registration is only open to Senior Scientists and above actively working in the?#pharmaceutical?/?#biotech?industry. Each roundtable is limited to 8 participants.?#hubXchangeNotAConference #lifesciences?#pharma?#pharmaceutical?#pharmacology?#biotech?#biotechnology?#biotechnews?#oligonucleotides?#therapeutics?#development?#manufacturing?#drugdevelopment?#drugdiscovery?#drugdelivery?#drugspharmaceuticals?#drugproduct?#drugmanufacturing?#drugsubstance

???????????????? ?????????? ???????? ????????????????: ???????????? ???????????????? ?????????????? ???????? ?????? ???????? ?????????????????? ???????? ?????? ?????? Discover how the AtlasGEN Novel Drug Designer is revolutionizing drug development from day one. Szczepan B. VeriSIM Life dives deep into the challenges of designing new drug molecules and presents innovative solutions to increase clinical success rates. With drug development costs soaring over $150 billion, even a 10% improvement in clinical translation could mean billions saved and countless lives improved. This whitepaper is a must-read for anyone in the pharmaceutical industry looking to streamline their ???????? ?????????????????? ??????????????. ?????????? ????????: https://lnkd.in/gqYYBaNG ???????????????? ????????????????????: https://lnkd.in/g-4kh8Z8 #DrugDiscovery #PharmaInnovation #ClinicalSuccess #DrugDevelopment #Biotech #Pharmaceuticals #AtlasGEN #SzczepanBaran #HealthcareInnovation #R&D #ClinicalTrials #MedicalResearch #PharmaIndustry #DrugDesign #PharmaNews

Accelerate drug development with Novum's 50 years of early-phase expertise. Why Choose Novum? We offer comprehensive capabilities with quick startup, a flexible approach to meet unique project needs, real-time communication for quick updates, proven success in meeting tight timelines, competitive pricing strategies enhancing cost-efficiency, and rapid turnaround times accelerating drug development. For in-depth insights and collaboration opportunities ?? [email protected]. #DrugDelivery #SelfAdministration #Pharmacokinetics #NovumPharma #RegulatoryCompliance #NovumPRS #ClinicalResearch #ClinicalTrials #ClinicalResearchExcellence #LasVegas #MedicalResearch #ClinicalDevelopment #GlobalCRO #FullserviceCRO #DrugDevelopment #Pharmaceuticals #Pharmaceutical #Research #Biopharma #InnovatewithNovum #LambdaTherapeuticResearch Lambda Therapeutic Research Dr. Mrinal Kammili Cathy Lopez Netal Desai, MD, MBA David Bell-Pruitt Niraj Shethji

#AI is revolutionizing the #pharmaceutical industry: Huge time savings possible in the development and approval process! Our Head of AI-First Experience Martin Weis is intensively involved in exploring the potential of AI in the pharmaceutical industry. In a recent interview with the Handelsblatt, he highlighted the immense opportunities of the technology: #GenerativeAI can save up to 50% of the time in the development and approval process! He sees huge opportunities especially in the early stages up to preclinical development: ● Faster identification of drug candidates ● More efficient development of new drugs ● Lower costs and shorter time to market AI can fundamentally change the pharmaceutical industry and lead to life-saving innovations. Find out more here https://lnkd.in/dnEjYrmE or reach out directly to Martin. #Pharma #Medicine #Innovation #Future #LifeSciences David Champeaux | Maximilian Schmid | Suraj Patil

You're invited! Join our new biomarker webinar series on kappa and lambda light chains presented by Cynthia Heape, scientific expert in #Agilent. Over the course of three educational webinars, Cindy will dive into the complex world of these fascinating proteins, addressing the obstacles, methodologies, and recent breakthroughs associated with their study and application. Whether you are a seasoned professional or new to the field, you will get the opportunity to broaden your understanding of kappa and lambda light chains. https://bit.ly/4eQz5Ay #pharmaceutical #biopharmaceutical